Patents
Patents for C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
10/2001
10/18/2001CA2404290A1 Ternary ligand complexes useful as radiopharmaceuticals
10/16/2001CA2086244C Method of preparing a radioactive rhenium complex solution
10/04/2001US20010027248 Obtained from rat forebrain; characterized by binding affinity for trans-(+)-6-acetyl-4S-(4-fluorobenzolamino) -3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3R-ol; therapy and prophylaxis of neurological disorders and/or drug withdrawal
09/2001
09/27/2001WO2001070755A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
09/20/2001WO2000071506A9 Naphthalene ureas as glucose uptake enhancers
09/13/2001WO2001005805A3 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof
09/04/2001CA2021550C Novel tritium marqued compounds, its preparation and application for finding of retinoid nuclear receptors
08/2001
08/28/2001US6281251 Contraceptives
08/22/2001CN1309661A Labelled glutamine and lysine analogues
08/21/2001US6277356 Somatostatin peptides, use as a radiopharmaceutical, e.g. for radiotherapy of somatostatin receptor tumors, complexed with y90
08/09/2001WO2000071506A3 Naphthalene ureas as glucose uptake enhancers
08/07/2001US6271425 Reacting an organic halide with oxygen molecules in the presence of an organotin compound and a reducing agent and optionally a free-radical inhibitor
08/01/2001EP1119356A1 Radiolabeled neurokinin-1 receptor antagonists
08/01/2001CN1306441A Pare-hydrogen labelled agents and their use in magnetic resonance imaging
07/2001
07/25/2001EP0862464A4 Amino acid analogs for tumor imaging
07/25/2001EP0642357B1 Radiolabelled somatostatin
07/05/2001US20010006619 Compounds for cancer imaging and therapy
07/03/2001US6255519 Radiolabelled pharmaceuticals and biological probes ueful in cancer diagnosis and treatment; imaging technology
06/2001
06/26/2001US6251363 Diagnostic and therapeutic alkylenediamine compounds and process
06/05/2001US6241964 F-18 radiolabeled neurokinin-1 receptor antagonists
05/2001
05/31/2001DE19949237A1 Vorstufenverbindung für Radiodiagnostika Precursor for diagnostic radiopharmaceuticals
05/25/2001WO2000078362A3 Stable, radioactively marked nanoparticles, method for the production and utilization thereof
05/17/2001WO2001034566A2 Protease inhibitors
05/16/2001EP1099693A1 Radiolabelled peptide compounds
05/01/2001US6224849 Alkylaminobenzothiazole and-benzoxazole derivatives
04/2001
04/24/2001US6221335 Method of using deuterated calcium channel blockers
04/19/2001WO2001027122A1 Pre-cursor for radiodiagnostic agents and the production thereof
04/19/2001WO2000053235A3 Radio labelled monomers and polymers
04/18/2001EP1092723A2 Bisphosphonic acid derivative and compound thereof labelled with radioactive nuclide
04/12/2001CA2322936A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive nuclide
04/10/2001CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
03/2001
03/22/2001DE19951715C1 New 18-fluoro-labeled cytosine derivatives, useful as tracers for monitoring activity of transferred cytosine deaminase genes in gene therapy of tumors
03/21/2001EP1084098A1 Inhibitors of the anandamide transporter as analgesic agents
03/21/2001EP1083858A2 Apparatus for the preparation of radioactive solutions
03/01/2001WO2000052031A3 Kit for radiolabeling proteins with yttrium-90
02/2001
02/28/2001EP1077998A1 Labelled glutamine and lysine analogues
02/22/2001WO2001012575A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
02/22/2001CA2378712A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
02/21/2001EP1077071A1 Labeled drugs and nitroxyl compounds to be used therein
02/20/2001US6190637 Method for preparing [F-18-]fluoride ion
02/13/2001US6187284 Reacting a peptide comprising a free thiol group with an 18 f-bound labelling reagent which also has a group that is reactive with thiols.
02/08/2001WO2001009146A1 Radiolabelled bisphosphonates and method
02/08/2001WO2001009095A1 Mutilin derivatives and their use as antibacterials
02/06/2001US6183721 A radioactive cyclic octapeptides for radiotherapy of somatostatin receptor positive tumors; antitumor agents
01/2001
01/30/2001US6180648 Analogs of cocaine
01/30/2001CA2124458C Technetium-99m labeled peptides for imaging
01/30/2001CA2101942C Technetium-99m labeled polypeptides for imaging
01/30/2001CA1341176C Macrocylic compounds
01/25/2001WO2001005805A2 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof
01/18/2001DE19934088A1 Neue C-19-halogensubstituierte Steroide der Androst-9(11)-en-Reihe, Verfahren zu ihrer Herstellung sowie ihre Verwendung New C-19 halogen-substituted steroids of androst-9 (11) -en-series, processes for their preparation and their use
01/10/2001EP1067103A2 Process for producing halogenated benzene compound
01/10/2001EP1066235A1 Synthetic endogenous cannabinoid analogues and uses thereof
01/09/2001US6172207 Method for synthesizing labelled compounds
01/02/2001US6169076 P-Boronophenylalanine complexes with fructose and related carbohydrates and polyols
01/02/2001US6168776 Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
12/2000
12/28/2000WO2000078362A2 Stable, radioactively marked nanoparticles, method for the production and utilization thereof
12/28/2000DE19928911A1 3-O-Methyl-6-(18-F)-fluoro-DOPA preparation in high radiochemical yield, for use in evaluating presynaptic dopaminergic function, by direct fluorination of 6-trimethylstannyl precursor
12/28/2000DE19928496A1 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes
12/27/2000EP1062190A1 Method for producing ?15 o] butanol and device for implementing said method
11/2000
11/30/2000WO2000071506A2 Naphthalene ureas as glucose uptake enhancers
11/30/2000CA2374225A1 Naphthalene ureas as glucose uptake enhancers
11/07/2000US6143274 Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
11/02/2000EP1047455A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging
10/2000
10/26/2000WO2000063216A1 F-18-labeled thia fatty acids and methods of making and using the same
10/19/2000WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/18/2000CN1057470C Ether isonitriles and radiolabeled complexes thereof
10/17/2000US6133259 Diagnosis of alzheimer's disease
10/17/2000US6132698 Stabilized solution of colorless organic compound with beta emitting nuclide of phosphorous and sulfur
10/12/2000WO2000059896A1 225Ac-HEHA AND RELATED COMPOUNDS, METHODS OF SYNTHESIS AND METHODS OF USE
10/11/2000EP0713513B1 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
10/05/2000WO2000058504A1 High throughput screening method for determining enantioselectivity
10/05/2000WO2000057887A1 p-BORONOPHENYLALANINE COMPLEXES WITH FRUCTOSE AND RELATED CARBOHYDRATES AND POLYOLS
10/05/2000CA2368749A1 High-throughput-screening method for determining enantioselectivity
09/2000
09/28/2000DE19913858A1 High-Throughput-Screening-Verfahren zur Bestimmung der Enantioselektivität asymmetrisch verlaufender Reaktionen High-throughput screening method for determining the enantioselectivity of asymmetric extending reactions
09/26/2000US6124440 Cores for technetium radiopharmaceuticals
09/14/2000WO2000053235A2 Radio labelled monomers and polymers
09/08/2000WO2000052031A2 Kit for radiolabeling proteins with yttrium-90
09/05/2000US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging
08/2000
08/29/2000US6111066 Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
08/22/2000US6106804 Arsenic-72 labeled compounds for tissue specific medical imaging
08/15/2000US6103725 High affinity to the dopamine d4 receptor; antagonists; antipsychotic agents, e.g. schizophrenia, with reduced side-effects; antipsychotic agents; anxiolytic and antiemetic agents; motoric functions, addiction, sleep, feeding
08/03/2000WO2000044747A1 Tropane derivatives as serotonin transporter antagonists
08/02/2000EP1023264A1 New marker, production process and use thereof
08/02/2000CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/01/2000US6096874 High affinity tamoxifen derivatives
07/2000
07/27/2000WO2000043004A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors
07/27/2000CA2361115A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors
07/19/2000EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
07/12/2000EP1017684A1 Contrasting agent for infarct and necrosis imaging
07/11/2000US6086850 Calcitonin receptor binding reagents
07/11/2000CA2168775C Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
07/05/2000EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
07/04/2000US6083480 Calcitonin receptor binding reagents
07/04/2000US6083479 Use of tetraazamacrocycle compounds
06/2000
06/28/2000EP1011737A2 Method for treating proliferative diseases by therapy
06/21/2000EP1009726A1 Fluorination of proteins and peptides for f-18 positron emission tomography
06/21/2000EP1009725A1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation
05/2000
05/24/2000CN1254346A Calcitonin receptor-binding peptides
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
04/2000
04/27/2000WO1999063547A9 Apparatus for the preparation of radioactive solutions
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27